| GB868605037AGB8605037D0 (en) | 1986-02-28 | 1986-02-28 | Oral pharmaceutical compositions |
| NL8602370ANL194822C (en) | 1985-10-01 | 1986-09-19 | Preparation for oral administration with controlled release and method for its preparation. |
| HU864004AHU197201B (en) | 1985-10-01 | 1986-09-19 | Process for producing oral pharmaceutical compositions of controlled solubility of the active components |
| CH3780/86ACH669524A5 (en) | 1985-10-01 | 1986-09-22 | |
| DE3632201ADE3632201C2 (en) | 1985-10-01 | 1986-09-23 | Pharmaceutical composition with sustained release of the active substance |
| GR862457AGR862457B (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
| KR1019860008136AKR920008817B1 (en) | 1985-10-01 | 1986-09-29 | Process for the preparing pharmaceutical formulations with controlled release of the active substance |
| IL80182AIL80182A (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance |
| AU63226/86AAU598751B2 (en) | 1985-02-07 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
| CA000519302ACA1298784C (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
| NZ217732ANZ217732A (en) | 1985-10-01 | 1986-09-29 | Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester |
| IE256586AIE59589B1 (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
| PT83456APT83456B (en) | 1985-10-01 | 1986-09-29 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERTACAOUS ACTIVE SUBSTANCE |
| SE8604112ASE503222C2 (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical preparations with controlled release of isradipine or darodipine |
| GB8623389AGB2181053B (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
| DK464686ADK170016B1 (en) | 1985-10-01 | 1986-09-29 | Composition with controlled release of the active substance |
| BE1/011554ABE905516A (en) | 1985-10-01 | 1986-09-30 | NEW EXTENDED RELEASE FORMULATION. |
| LU86615ALU86615A1 (en) | 1985-10-01 | 1986-09-30 | NEW EXTENDED RELEASE FORMULATION |
| ES8602313AES2002508A6 (en) | 1985-10-01 | 1986-09-30 | New sustained-release formulation based on pindolol |
| IT8648494AIT1214719B (en) | 1985-10-01 | 1986-09-30 | Controlled release cardiovascular preparations |
| AT0260486AAT402257B (en) | 1985-10-01 | 1986-09-30 | METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF A 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINE DICARBOXYLATE ESTER ACTIVE SUBSTANCE |
| FR868613668AFR2589732B1 (en) | 1985-10-01 | 1986-10-01 | NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL |
| SG1033/91ASG103391G (en) | 1985-10-01 | 1991-12-04 | Pharmaceutical formulations with controlled release of the active substance |
| HK3/92AHK392A (en) | 1985-10-01 | 1992-01-02 | Pharmaceutical formulations with controlled release of the active substance |
| CY1622ACY1622A (en) | 1985-10-01 | 1992-07-10 | Pharmaceutical formulations with controlled release of the active substance |